Notice2025-00161

Agency Forms Undergoing Paperwork Reduction Act Review

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 8, 2025

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 5 (Wednesday, January 8, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 5 (Wednesday, January 8, 2025)]
[Notices]
[Pages 1492-1493]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-00161]



[[Page 1492]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-25-1046]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``National Breast and Cervical Cancer Early 
Detection Program (NBCCEDP) Monitoring Activities'' to the Office of 
Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on October 1, 2024 to obtain comments from the 
public and affected agencies. CDC received five non-substantive 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) Monitoring Activities (OMB Control No. 0920-1046, Exp. 3/31/
2025)--Revision--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    CDC is requesting a Revision of the information collection (OMB 
Control No. 0920-1046), titled National Breast and Cervical Cancer 
Early Detection Program (NBCCEDP) Monitoring Activities. Information 
collection consists of an annual NBCCEDP survey, baseline and annual 
clinic-level data collection, a quarterly program update (QPU) tool, a 
service delivery projection worksheet, and minimum data elements 
(MDEs). CDC proposes revisions to the Annual NBCCEDP Survey, clinic-
level data collection tool and quarterly program update (QPU), and 
continued use of the service delivery projection worksheet and MDEs 
with no changes. The number of respondents will increase from 70 to 71 
and the total estimated annualized burden will decrease from 1,220 
hours to 1,162 hours.
    Breast and cervical cancers are prevalent among U.S. women. 
Evidence shows that deaths from both breast and cervical cancers can be 
avoided by increasing screening services--mammography, pap, and human 
papillomavirus (HPV) tests--among women. However, screening is 
typically underutilized among women who are under- or uninsured, have 
no regular source of healthcare, or who recently immigrated to the U.S.
    To improve access to cancer screening, Congress passed the Breast 
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 106-354), 
which directed CDC to create the National Breast and Cervical Cancer 
Early Detection Program (NBCCEDP). The NBCCEDP currently provides 
funding to 71 recipients under ``Cancer Prevention and Control Programs 
for State, Territorial, and Tribal Organizations (DP22-2202).'' The 
purpose of NBCCEDP is to increase breast and cervical cancer screening 
rates among women residing within defined geographical locations (as 
determined by the funded program) who are at or below 250% of the 
federal poverty level; aged 50-75 years for breast cancer services, and 
aged 21-64 years for cervical cancer services; and are runder- or 
uninsured.
    CDC proposes revisions to three of the five information 
collections:
    <bullet> Annual NBCCEDP Survey--submitted to CDC annually and 
collects program-level information to monitor recipients' challenges, 
external funding sources, partnerships, and EBI implementation. The 
survey has been revised to add questions related to partnership 
activities and recipients' requirements for patients' payments towards 
screening services, and remove COVID-19-related questions.
    <bullet> Clinic-level data collection--submitted to CDC at baseline 
and annually to assess health system, clinic, and patient population 
characteristics; monitoring and quality improvement activities; EBI 
implementation; and baseline or annual screening rates. The tool has 
been revised to remove COVID-19-related variables and update response 
options for measures used to report breast and cervical cancer 
screening rates.
    <bullet> QPU--submitted to CDC four times per year to monitor award 
spending, service delivery, staff vacancies, program challenges and 
successes, and technical assistance (TA) needs. This instrument has 
been revised to include two optional open-ended items for recipients to 
provide context to reported service delivery and spending data if 
needed.

CDC proposes continued use of the remaining two information 
collections--the Service Delivery Project Worksheet and the MDEs--which 
have not been changed.

    To maximize consistency in our routine data collections for the 
current NBCCEDP funding cycle, CDC has not revised NBCCEDP information 
collections to align with the Department of Health and Human Services 
(HHS)' current best practices for demographic questions related to 
sexual orientation and gender identity (SOGI) and race and ethnicity 
(R/E) at this time. However, CDC plans to revise information 
collections that include demographic items to align with HHS' SOGI and 
R/E guidelines for the next funding cycle beginning in 2027. The 
proposed modifications to the information collections will allow CDC to 
better

[[Page 1493]]

gauge progress in meeting NBCCEDP program goals and monitor 
implementation activities, evaluate outcomes, and identify awardee 
technical assistance needs. In addition, findings will inform program 
improvement and help identify successful activities that need to be 
maintained, replicated, or expanded.
    CDC requests OMB approval for three years and for an estimated 
1,162 annual burden hours. Participation is required for NBCCEDP 
awardees. There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent       (in hrs)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Recipients....................  Annual NBCCEDP Survey...              71               1           46/60
                                        NBCCEDP Clinic-level                  71               6           40/60
                                         Information Collection
                                         Instrument--Breast.
                                        NBCCEDP Clinic-level                  71               6           40/60
                                         Information Collection
                                         Instrument--Cervical.
                                        Quarterly Program Update              71               4           32/60
                                        Service Delivery                      71               1           29/60
                                         Projection Worksheet.
                                        MDEs....................              71               2          150/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2025-00161 Filed 1-7-25; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>
Indexed from Federal Register on January 8, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.